ICON plc vs Eli Lilly & Co.
ICLR vs LLY — side-by-side comparison from reported financials. ICLR leads 1, LLY leads 10 of 11 comparable metrics.
ICON plc
ICLR · Healthcare
$164.17-0.20%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | ICLR | LLY |
|---|---|---|
| Price | $164.17 | $1 177.20 |
| Market cap | $12.7B | $1.05T |
| Revenue (TTM) | $8.25B | $79.7B |
| Revenue growth | +2.1% | +31.7% |
| Net margin | 2.6% | 33.5% |
| Free cash flow | $1.03B | $18.2B |
| Net cash (debt) | ($2.60B) | ($35.2B) |
| 1-year price return | -12.5% | +37.6% |
| P/E | 182.1 | 41.6 |
| P/E vs own history (cheap-side %) | 32% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 1% | 93% |
| Altman Z-score | 1.88 | 7.10 |
| CV checks passed | 7 of 10 | 11 of 10 |
| Employees | 40,100 | 50,000 |
Full résumé-style profiles: ICLR CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.